Jaguar Animal Health, Inc. JAGX
7.70
0.64
9.07%
as of 25 Sep
- Market cap
- $3.8M
- P/E
- 0.1×
Follow JAGX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
2.83 | 9.53 | 4.87 | 0.00 | 0.00 | 198,201,062.85 | 122,027,886.88 | 134,870,293.78 | 18,282,754,417.67 | 9,661,624,906,836.67 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(5.94) | (14.23) | (6.38) | 0.00 | 0.00 | (458,044,071.62) | (224,430,269.65) | (121,504,323.01) | (14,958,991,443.11) | (501,290,673,334.33) |
P/B ratio |
0.00 | 17.15 | 9.71 | 0.00 | 0.00 | 108,133,762.05 | 78,642,009.45 | 110,645,202.84 | 4,619,252,667.34 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
3.81 | 11.20 | 7.80 | 2.40 | 2.63 | 198,201,063.72 | 122,027,887.51 | 134,870,295.98 | 18,282,754,420.39 | 9,661,624,906,852.75 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(1.85) | (4.45) | (2.29) | (0.87) | (0.33) | (121,751,340.68) | (34,448,406.43) | (26,202,958.15) | (8,115,392,553.89) | (94,848,645,685.68) |
EV/FCF |
(1.80) | (4.19) | (2.11) | (0.80) | (0.33) | (121,695,582.79) | (34,436,622.87) | (26,195,467.41) | (8,030,226,334.99) | (94,167,884,082.39) |
Quick Ratio |
0.23 | 0.49 | 0.62 | 0.26 | 1.24 | 0.96 | 0.36 | 0.13 | 0.08 | 0.35 |
Current Ratio |
0.50 | 1.63 | 2.00 | 0.74 | 1.84 | 1.35 | 0.62 | 0.31 | 0.25 | 0.61 |
Net Debt/EBITDA |
(0.17) | (0.55) | (1.31) | (1.41) | (0.34) | (0.37) | (0.17) | (0.59) | (0.73) | (0.17) |
Debt/Assets |
39.36% | 43.99% | 61.05% | 71.88% | 53.40% | 37.84% | 20.78% | 39.19% | 28.86% | 104.89% |
Debt/Equity |
(0.81) | 3.62 | 6.33 | (25.15) | 2.40 | 0.94 | 0.37 | 1.12 | 0.73 | (1.52) |
Asset Turnover |
0.25 | 0.22 | 0.20 | 0.24 | 0.09 | 0.24 | 0.15 | 0.10 | 0.18 | 0.02 |
Operating CF/Net income |
0.44 | 0.76 | 0.80 | 0.70 | 0.66 | 0.40 | 0.46 | 0.71 | 0.45 | 0.98 |
Capex/Depreciation |
(0.02) | (0.09) | 0.00 | (0.12) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.19) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 729.95% | (675.83%) | (2,332.67%) | (904.14%) | (362.04%) | (295.44%) | (623.62%) | (283.92%) | (296.74%) | (1,515.12%) | |
| (116.79%) | (73.89%) | (84.10%) | (94.23%) | (109.45%) | (97.53%) | (115.49%) | (75.93%) | (93.10%) | (184.54%) | |
ROIC |
0.00% | (87.61%) | (72.85%) | (78.83%) | (109.44%) | (65.77%) | (74.61%) | (69.05%) | (73.57%) | 0.00% |
Return on Tangible Assets |
269.95% | (297.05%) | (285.38%) | 636.03% | (386.36%) | (736.29%) | 866.78% | 181.12% | 211.96% | 1,959.28% |
Average Days of Receivables |
53.84 | 51.43 | 81.67 | 75.31 | 180.52 | 177.35 | 107.07 | 82.80 | 39.25 | 12.90 |
Research and Development Expense of Revenue |
216.89% | 141.52% | 190.51% | 147.60% | 347.84% | 68.33% | 100.78% | 116.73% | 97.90% | 5,093.22% |
Selling, General and Administrative Expense of Revenue |
242.19% | 205.52% | 236.12% | 223.36% | 599.70% | 223.72% | 353.90% | 500.64% | 328.61% | 4,571.52% |
Intangible Assets out of Total Assets |
0.42 | 0.35 | 0.40 | 0.47 | 0.43 | 0.57 | 0.71 | 0.77 | 0.88 | 0.00 |
Share Based Compensation of Revenue |
7.22% | 14.12% | 23.39% | 34.64% | 92.04% | 40.58% | 54.18% | 45.97% | 19.68% | 507.35% |
Graham Net Nets |
(1.12) | (0.13) | (0.38) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
2,379.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.60 |
Earnings Yield |
(162.19%) | (35.52%) | (78.14%) | (44.60%) | (2.00%) | 0.00% | (16.74%) | (21.92%) | 0.00% | 0.00% |
Free Cash Flow Yield |
(74.76%) | (28.03%) | (75.90%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
172.58 | 1,391.55 | 24,402.50 | 0.00 | 0.00 | 0.73 | 1.16 | 21.06 | 1.51 | 0.01 |
Operating CF per Share |
(355.11) | (3,498.10) | (83,105.00) | 0.00 | 0.00 | (1.19) | (4.12) | (108.40) | (3.39) | (1.32) |
Capex per Share |
(0.61) | (27.50) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.03) | 0.00 | (0.01) |
Free Cash Flow per Share |
(355.73) | (3,525.60) | (83,105.00) | 0.00 | 0.00 | (1.19) | (4.12) | (108.43) | (3.39) | (1.33) |
Cash per Share |
117.42 | 952.62 | 16,172.50 | 0.00 | 0.00 | 0.63 | 0.78 | 12.25 | 0.26 | 0.13 |
Shareholders Equity per Share |
(280.18) | 773.10 | 12,242.50 | 0.00 | 0.00 | 1.34 | 4.14 | 68.59 | 5.96 | (0.22) |
Interest Debt per Share |
0.00 | 0.00 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(280.18) | 773.10 | 12,242.50 | 0.00 | 0.00 | 1.34 | 4.14 | 68.59 | 5.96 | (0.22) |
Free Cash Flow |
(23.73) | (29.61) | (33.24) | (34.78) | (34.98) | (15.28) | (20.46) | (22.74) | (9.82) | (14.52) |
Working Capital |
(20.31) | 12.49 | 13.98 | (8.02) | 12.96 | 4.57 | (5.87) | (18.51) | (11.59) | (1.64) |
Capital Expenditures |
(0.04) | (0.23) | 0.00 | (1.67) | (0.01) | (0.01) | — | (0.01) | — | (0.10) |
Net Current Asset Value |
(36.67) | (14.73) | (17.90) | (26.49) | (12.98) | (7.85) | (6.32) | (18.51) | (22.57) | (3.46) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.02 | 0.00 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.74 |
Net Profit Margin |
(465.42%) | (329.30%) | (423.11%) | (396.91%) | (1,213.26%) | (411.81%) | (774.48%) | (727.93%) | (503.73%) | (10,412.58%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
5.09 | 5.67 | 31.44 | 25.22 | 10.74 | 7.31 | 9.98 | 10.16 | 14.74 | 0.63 |
Cash ROIC |
(571.30%) | (78.55%) | (79.65%) | (88.06%) | (62.11%) | (38.44%) | (66.11%) | (71.11%) | (36.09%) | (557.30%) |
Accounts Receivable Turnover |
6.88 | 6.10 | 4.20 | 5.19 | 1.29 | 3.00 | 4.28 | 6.01 | 18.40 | 4.65 |
Accounts Payable Turnover |
0.54 | 0.38 | 0.38 | 0.38 | 0.48 | 0.65 | 0.71 | 0.43 | 0.22 | 0.10 |
Inventory Turnover |
0.40 | 0.20 | 0.25 | 0.34 | 0.61 | 1.34 | 1.39 | 1.02 | 0.71 | 0.16 |
Average Days of Payables |
840.06 | 986.90 | 891.27 | 1,049.99 | 771.15 | 529.58 | 511.92 | 714.55 | 3,049.23 | 3,628.94 |
Days of Inventory on Hand |
831.65 | 1,931.42 | 1,646.53 | 1,269.82 | 766.61 | 309.58 | 203.64 | 441.08 | 859.35 | 2,897.54 |
Average Receivables |
1.67 | 1.92 | 2.33 | 2.31 | 3.35 | 3.13 | 1.35 | 0.74 | 0.24 | 0.03 |
Average Payables |
6.99 | 5.13 | 5.39 | 5.37 | 4.84 | 5.06 | 5.38 | 6.38 | 3.94 | 0.55 |
Average Inventory |
9.47 | 9.77 | 8.11 | 5.96 | 3.84 | 2.46 | 2.74 | 2.71 | 1.24 | 0.32 |
Average Assets |
45.87 | 52.09 | 49.11 | 50.36 | 48.05 | 39.63 | 38.73 | 42.34 | 23.60 | 7.98 |
Average Common Equity |
(7.34) | 5.70 | 1.77 | 5.25 | 14.53 | 13.08 | 7.17 | 11.32 | 7.40 | 0.97 |
Columns are period end dates